Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.66USD
19 Jul 2019
Change (% chg)

$-0.08 (-2.14%)
Prev Close
$3.74
Open
$3.73
Day's High
$3.79
Day's Low
$3.65
Volume
46,997
Avg. Vol
50,313
52-wk High
$4.99
52-wk Low
$2.33

Dey, Bruce 

Mr. Bruce A. Dey is Vice President - Sales and Marketing, Enzo Clinical Labs of the company. Prior to joining Enzo Clinical Labs, Mr. Dey served as Vice President, Sales & Marketing for CDS Laboratories from 1989 to 2001, which was acquired by Quest Diagnostics in November 2001. He began his career with SmithKline Beecham Clinical Laboratories. Mr. Dey earned a Bachelor of Science in Economics and a Master of Business Administration from The State University of New York at Albany.

Basic Compensation

Total Annual Compensation, USD 448,565
Restricted Stock Award, USD 8,840
Long-Term Incentive Plans, USD --
All Other, USD 39,091
Fiscal Year Total, USD 496,496

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018